Diwa, Hindon A.

HRN: 28-08-90  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2026
CEFUROXIME 500MG (TAB)
05/17/2026
05/24/2026
PO
500mg
BID X 7 Days
Thickly MSAF
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines